Fatima Faraz

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Decision Making

Acute Myeloid Leukemia

Top Venues

Cancer reports (Hoboken, N.J.)

Health science reports

This page only lists publications with an associated author ORCID identifier.

Publications

Mohammad Ebad Ur Rehman, Fatima Faraz, Huzaifa Ahmad Cheema, Omer S Ashruf, Hamna Raheel, Syeda Zainab Ali Naqvi, Nimrah Jabeen, Areesha Abid, Haris Mumtaz Malik, Ahmad Iftikhar, Ahmed Ibrahim, Sarya Swed
Impact of prior cancer history on survival in brain malignancy: A propensity score-adjusted, population-based study. Cancer reports (Hoboken, N.J.) 7 (2) (2024)
Areeba Fareed, Aariz Hussain, Fatima Faraz, Rima Siblini
First case of MPox in Pakistan: What can we learn from it? Health science reports 7 (1) (2024)
Mohammad Ebad Ur Rehman, Fatima Faraz, Huzaifa Ahmad Cheema, Omer S Ashruf, Hamna Raheel, Syeda Zainab Ali Naqvi, Nimrah Jabeen, Areesha Abid, Haris Mumtaz Malik, Ahmad Iftikhar, Ahmed Ibrahim, Sarya Swed
Impact of prior cancer history on survival in brain malignancy: A propensity score-adjusted, population-based study. Cancer reports (Hoboken, N.J.) 7 (2) (2024)
Areeba Fareed, Aariz Hussain, Fatima Faraz, Rima Siblini
First case of MPox in Pakistan: What can we learn from it? Health science reports 7 (1) (2024)
Areeba Fareed, Nimrah Inam, Fatima Faraz
Breakthrough treatment choice for Acute Myeloid Leukemia in pediatric and adult patients: Revumenib, an oral selective inhibitor of KMTA2Ar. Rare tumors 15 (2023)